165 related articles for article (PubMed ID: 17667600)
1. Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
Jönsson P; Höglund P; Wiebe T; Schrøder H; Seidel H; Skärby T
Anticancer Drugs; 2007 Sep; 18(8):941-8. PubMed ID: 17667600
[TBL] [Abstract][Full Text] [Related]
2. [Cerebrospinal fluid methotrexate level in children treated with medium-high and high doses of the drug].
Wysocki M; Balcar-Boroń A; Krzyzanowski M; Szadujkis-Szadurski L; Ozyński T; Nowaczyk-Michalak A
Acta Haematol Pol; 1992; 23(3):185-90. PubMed ID: 1492543
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of methotrexate given intrathecally to children with acute lymphoblastic leukemia.
Skibińska L; Daszkiewicz P; Michalewska D; Radwańska U
Pol J Pharmacol Pharm; 1988; 40(2):135-43. PubMed ID: 3237563
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect.
Evans WE; Crom WR; Abromowitch M; Dodge R; Look AT; Bowman WP; George SL; Pui CH
N Engl J Med; 1986 Feb; 314(8):471-7. PubMed ID: 3456079
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate.
Wang JJ; Freeman AI; Sinks LF
Cancer Res; 1976 Apr; 36(4):1441-4. PubMed ID: 1063065
[TBL] [Abstract][Full Text] [Related]
6. [Central nervous system leukemia in adults with acute lymphoblastic leukemia].
Tomić D; Bosković D; Beslać-Bumbasirević Lj; Rolović Z
Srp Arh Celok Lek; 1989; 117(11-12):727-36. PubMed ID: 2490990
[TBL] [Abstract][Full Text] [Related]
7. Neuroimmunitary profile estimation in cerebrospinal fluid and its importance in childhood acute lymphoblastic leukaemia.
Crivii SM; Neamtu S; Bocsan G
Arch Geschwulstforsch; 1989; 59(3):199-204. PubMed ID: 2757478
[TBL] [Abstract][Full Text] [Related]
8. CNS relapse in children with acute lymphoblastic leukemia after cranial prophylaxis.
Pai SK; Koppikar SB; Sanchetee SC; Pai VR; Kurkure PA; Choudhary AJ; Shetty PA
Indian J Cancer; 1988 Sep; 25(3):165-71. PubMed ID: 3224988
[No Abstract] [Full Text] [Related]
9. [Abnormally high methotrexate levels in the cerebrospinal fluid after intravenous and intrathecal treatment for acute lymphoblastic leukemia].
Négre V; Leneveu A; Chevallier B; Roux A
Arch Fr Pediatr; 1991 Jan; 48(1):63. PubMed ID: 2018429
[No Abstract] [Full Text] [Related]
10. [Adenosine deaminase activity in the cerebrospinal fluid of children with acute lymphoblastic leukemia].
Lastowska M
Acta Haematol Pol; 1989; 20(2):152-7. PubMed ID: 2638533
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics.
Bleyer AW
Cancer Treat Rep; 1977 Nov; 61(8):1419-25. PubMed ID: 579164
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection.
Bleyer WA; Dedrick RL
Cancer Treat Rep; 1977 Jul; 61(4):703-8. PubMed ID: 577895
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system and testicular involvement in acute lymphoblastic leukaemia.
Saikia TK; Gopal R; Nair CN; Nadkarni KS; Dinshaw KA; Kamat DM; Rao DN; Advani SH
J Assoc Physicians India; 1985 Jul; 33(7):457-9. PubMed ID: 3863812
[No Abstract] [Full Text] [Related]
14. 7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia.
Borsi JD; Sagen E; Romslo I; Slørdal L; Moe PJ
Cancer Chemother Pharmacol; 1990; 27(2):164-7. PubMed ID: 2249335
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate concentration levels in the cerebrospinal fluid during high-dose methotrexate infusions: an unreliable prediction.
Lippens RJ; Winograd B
Pediatr Hematol Oncol; 1988; 5(2):115-24. PubMed ID: 3152957
[TBL] [Abstract][Full Text] [Related]
16. The significance of an isolated central nervous system relapse, occurring as first relapse in children with acute lymphoblastic leukemia.
Behrendt H; van Leeuwen EF; Schuwirth C; Verkes RJ; Hermans J; van der Does-van den Berg A; van Wering ER
Cancer; 1989 May; 63(10):2066-72. PubMed ID: 2702576
[TBL] [Abstract][Full Text] [Related]
17. The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia.
Pearson AD; Amineddine HA; Yule M; Mills S; Long DR; Craft AW; Chessells JM
Br J Cancer; 1991 Jul; 64(1):169-73. PubMed ID: 1854617
[TBL] [Abstract][Full Text] [Related]
18. The treatment of childhood acute lymphoblastic leukemia based on the pharmacokinetics of methotrexate in serum and cerebrospinal fluid.
Muchi H; Ijima H; Karube T
Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1397-408. PubMed ID: 3867213
[No Abstract] [Full Text] [Related]
19. Twelve years experience with methotrexate infusions in childhood ALL.
Moe PJ; Seip M; Wesenberg F; Kolmannskog S
An Esp Pediatr; 1988 Oct; 29 Suppl 34():54-8. PubMed ID: 3214038
[No Abstract] [Full Text] [Related]
20. [Selenium concentration in the cerebrospinal fluid of children].
Haas HJ; Kopka ER; Sitzmann FC
Padiatr Padol; 1987; 22(1):43-9. PubMed ID: 3473410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
